Hatch BioFund — Seed & Pre-Seed VC Firm ($250K–$2.0M Checks)
Hatch BioFund is a Seed, Pre-Seed venture capital firm based in Doylestown, Pennsylvania, United States investing in Healthcare, AI / ML, Other. The firm typically writes $250K–$2.0M checks and has 7 portfolio companies in our records.
- Check size
- $250K–$2.0M
- Portfolio
- 7 companies on record
- Partners
- 1 listed
- AUM
- $50M
- Stage
- Seed, Pre-Seed
- Sectors
- Healthcare, AI / ML, Other, SaaS, Enterprise
- HQ
- Doylestown, Pennsylvania, United States
Last verified: 2026-09-08
Seed, Pre-Seed
$250K – $2.0M
$50M
7+ companies
1 partner
Investment Thesis
Invests in private companies developing therapeutics and vaccines for human use, across all development stages and modalities, with a preference for capital efficiency, well-understood disease biology, clear development paths, and experimental medicines with strong commercial rationale.
How Hatch BioFund invests
Hatch BioFund is a vc firm based in Doylestown, Pennsylvania, United States. The firm invests at the Seed, Pre-Seed stages, with a focus on Healthcare, AI / ML, Other, SaaS, Enterprise.
Hatch BioFund typically writes checks of $250K–$2.0M per investment, backed by approximately $50M in assets under management.
Hatch BioFund has backed 7 companies in our records, including PathScan AI, WorkCycle, Vittoria Biotherapeutics, Inc..
Partners & Team
Industry Focus
Invests In
Portfolio Companies (7)
Other
PathScan AI
WorkCycle
Vittoria Biotherapeutics, Inc.
Developing novel CAR T cell therapies that transcend the limitations of current cell therapies.
Latus Bio
A patient-centric gene therapy company with a robust pipeline of product candidates in development for both rare and common CNS diseases.
Hula Therapeutics
A spinout from the Children's Hospital of Philadelphia focusing on identifying highly specific immunotherapy targets essential to tumors.
MasterSwitch Bio
Developed a modified mRNA therapy targeting Hepatocyte Nuclear Factor-4 alpha for the treatment of End Stage Liver Disease with cirrhosis.
Ladder Bio
Developed a novel chemical platform of synthetic, modular, fused-ring peptide-like structures for highly selective binding of proteins.
- •Raising at Seed, Pre-Seed? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, AI / ML, Other — the sectors they actively back.
- •Size your ask to their typical $250K – $2.0M check.
- •cold outreach ok
- •Address your outreach to a specific partner, such as Lorenzo Pellegrini, Ph.D., Managing Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Hatch BioFund is a match for your startup
Upload your pitch deck to see how well you match with Hatch BioFund and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal